Insider Transactions in Q1 2024 at Mersana Therapeutics, Inc. (MRSN)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct |
10,409
-4.96%
|
$20,818
$2.71 P/Share
|
|
Jan 16
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,025
-17.72%
|
$10,050
$2.71 P/Share
|
|
Jan 16
2024
|
Tushar Misra SVP, Chief Manuf. Officer |
SELL
Open market or private sale
|
Direct |
3,357
-15.74%
|
$6,714
$2.71 P/Share
|
|
Jan 16
2024
|
Anna Protopapas Director |
SELL
Open market or private sale
|
Direct |
29,399
-19.02%
|
$58,798
$2.71 P/Share
|
|
Jan 16
2024
|
Mohan Bala SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,431
-19.62%
|
$6,862
$2.71 P/Share
|
|
Jan 16
2024
|
Brian De Schuytner SVP, COO & CFO |
SELL
Open market or private sale
|
Direct |
9,327
-14.61%
|
$18,654
$2.71 P/Share
|
|
Jan 16
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,381
-13.78%
|
$8,762
$2.71 P/Share
|
|
Jan 15
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,208
+3.56%
|
-
|
|
Jan 15
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,352
+8.48%
|
-
|
|
Jan 15
2024
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
38,958
+11.86%
|
-
|
|
Jan 15
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,208
+7.64%
|
-
|
|
Jan 14
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+2.4%
|
-
|
|
Jan 14
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,783
+17.21%
|
-
|
|
Jan 14
2024
|
Tushar Misra SVP, Chief Manuf. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,458
+6.4%
|
-
|
|
Jan 14
2024
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,750
+12.66%
|
-
|
|
Jan 14
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+10.1%
|
-
|
|
Jan 14
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.29%
|
-
|
|
Jan 13
2024
|
Timothy B Lowinger SVP, Chief Sci.&Tech. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+4.71%
|
-
|
|
Jan 13
2024
|
Ashish Mandelia VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,645
+12.68%
|
-
|
|
Jan 13
2024
|
Tushar Misra SVP, Chief Manuf. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,083
+26.28%
|
-
|
|
Jan 13
2024
|
Anna Protopapas Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+24.02%
|
-
|
|
Jan 13
2024
|
Mohan Bala SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+33.35%
|
-
|
|
Jan 13
2024
|
Brian De Schuytner SVP, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.43%
|
-
|
|
Jan 13
2024
|
Alejandra Carvajal SVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,958
+23.42%
|
-
|
|
Jan 02
2024
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,810
+1.47%
|
-
|
|
Jan 02
2024
|
Willard H Dere Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,112
+13.49%
|
-
|